Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Buy
30,426
+450
+2% +$52.7K 0.53% 49
2026
Q1
$3.61M Sell
29,976
-594
-2% -$68.6K 0.54% 53
2025
Q4
$3.22M Sell
30,570
-8,760
-22% -$822K 0.42% 58
2025
Q3
$3.3M Sell
39,330
-38,258
-49% -$3.15M 0.44% 58
2025
Q2
$6.14M Sell
77,588
-11,219
-13% -$892K 0.91% 31
2025
Q1
$7.97M Buy
+88,807
New +$8.29M 1.5% 12

Other funds holding MRK

S-Bank Fund Management's MRK Position: Q2 2026 in Review

S-Bank Fund Management increased its Merck (MRK) stake by 1.5% in Q2 2026, buying an estimated $52.7K and bringing the position to 30,426 shares worth $3.91M. The position accounts for 0.53% of the portfolio, ranked #49.

S-Bank Fund Management first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.97M in Q1 2025. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • S-Bank Fund Management held 30,426 shares of Merck worth $3.91M as of Q2 2026.
  • S-Bank Fund Management bought 450 Merck shares in Q2 2026, an estimated $52.7K.
  • Merck made up 0.53% of S-Bank Fund Management's portfolio in Q2 2026, its #49 holding.
  • S-Bank Fund Management first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • S-Bank Fund Management's Merck position peaked at $7.97M in Q1 2025.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.